Quarter Financials

Aeglea BioTherapeutics, Inc. (AGLE)

$11.66

-0.59 (-4.82%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Net Income -217-18-19-18-22-24-20-20
Dividend Paid --------
Retained Earnings -661-444-426-407-389-366-342-321

PPE Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
Capital Expenditure ----0--0--0
Net PPE 27778889

Intangible and Goodwill Schedule

Year 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3
New Purchases -26-13-4-24-7-5--
Intangible and Goodwill --------